Anti-atherosclerotic effects of PPAR gamma ligands

Shu Wakino

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)

Abstract

Peroxisome proliferator-activated receptor gamma(PPAR gamma) belongs to a nuclear receptor super family which is activated by insulin sensitizer, thiazolidinediones. The expression of PPAR gamma was detected in the vascular tissues and PPAR gamma ligands have various effects on all cells which constitute the vasculature including endothelial cells, vascular smooth muscle cells and monocytes/macrophages. The net effect by PPAR gamma ligands is proven to be anti-atherosclerosis. In various atherosclerogenic mouse models and balloon injury model, PPAR gamma ligands attenuate atherosclerotic lesion formation and intimal hyperplasia. In human study, various beneficial effects by PPAR gamma ligands were reported in terms of atherogenesis. PPAR gamma ligands attenuate the increase in intima-media thickness in diabetic patients. However, long-term effects remain to be seen.

Original languageEnglish
Pages (from-to)180-186
Number of pages7
JournalNippon rinsho. Japanese journal of clinical medicine
Volume62
Issue number1
Publication statusPublished - 2004 Jan
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Anti-atherosclerotic effects of PPAR gamma ligands'. Together they form a unique fingerprint.

Cite this